Kroes R, Walker R
Institute for Risk Assessment Sciences (IRAS), Utrecht University, P.O. Box 80176, NL-3508 TD Utrecht, The Netherlands.
Toxicology. 2004 May 20;198(1-3):213-20. doi: 10.1016/j.tox.2004.01.028.
Although botanicals have played a role in the marketing of health products for ages, there is an increased interest today due to their perceived health benefits. Not only do consumers increasingly take charge of their health, but the scientific information and understanding of the beneficial health effects of bioactive substances in food, functional foods and food supplements have improved. Increasing use of these products has also led to concerns about their actual safety. Recorded cases of intoxications have triggered such concerns. The safety assessment of these substances is complicated by, amongst others, the variability of composition. Furthermore, consumption of such functional products is expected to produce physiological effects, which may lead to low margins of safety as the margin between exposure of such products and the safe level of intake are likely to be small. The safety assessment of botanicals and botanical preparations in food and food supplement should at least involve: the characterisation and quality of the material, its quality control; the intended use and consequent exposure; history of use and exposure; product comparison(s); toxicological information gathering; Risk characterisation/safety assessment. As a guidance tool, a decision tree approach is proposed to assist in determining the extent of data requirements based on the nature of the such product. This guidance tool in safety assessment was developed by an expert group of the International Life Sciences Institute (ILSI), European Branch, and is currently in press. In this paper a summarised version of this tool is presented.
尽管植物药在健康产品营销中已发挥作用多年,但由于人们认为其具有健康益处,如今对其的兴趣与日俱增。消费者不仅越来越关注自身健康,而且对食品、功能食品和食品补充剂中生物活性物质有益健康作用的科学信息及理解也有所提高。这些产品使用的增加也引发了对其实际安全性的担忧。已记录的中毒案例引发了此类担忧。这些物质的安全性评估因成分的变异性等因素而变得复杂。此外,食用此类功能性产品预计会产生生理效应,由于此类产品的摄入量与安全摄入量之间的差距可能很小,这可能导致安全边际较低。食品和食品补充剂中植物药及植物制剂的安全性评估至少应包括:物质的特性和质量、其质量控制;预期用途及由此产生的暴露情况;使用和暴露历史;产品比较;毒理学信息收集;风险特征描述/安全性评估。作为一种指导工具,本文提出了一种决策树方法,以协助根据此类产品的性质确定数据要求的范围。这种安全性评估指导工具由国际生命科学研究所(ILSI)欧洲分会的一个专家组开发,目前正在出版中。本文给出了该工具的一个简化版本。